Search

Sergio Coffa

Examiner (ID: 9433, Phone: (571)270-3022 , Office: P/1675 )

Most Active Art Unit
1658
Art Unit(s)
1676, 1658, 1675, 1654
Total Applications
931
Issued Applications
452
Pending Applications
139
Abandoned Applications
357

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18739583 [patent_doc_number] => 20230348539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => A NEW ANTIBIOTIC SELECTIVELY KILLS GRAM-NEGATIVE PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/778785 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778785 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778785
Antibiotic selectively kills gram-negative pathogens Nov 19, 2020 Issued
Array ( [id] => 16977623 [patent_doc_number] => 20210221860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => APPLICATION OF RECOMBINANT HUMAN SECRETORY DDRGK1 [patent_app_type] => utility [patent_app_number] => 16/952391 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4841 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952391 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952391
Use of recombinant human secretory DDRGK1 Nov 18, 2020 Issued
Array ( [id] => 16839484 [patent_doc_number] => 20210147496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => PEPTIDES, HYDROGEL COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/098629 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098629 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098629
Peptides, hydrogel compositions and methods of use thereof Nov 15, 2020 Issued
Array ( [id] => 16824255 [patent_doc_number] => 20210139548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NPY2 RECEPTOR AGONISTS [patent_app_type] => utility [patent_app_number] => 17/093680 [patent_app_country] => US [patent_app_date] => 2020-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093680 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/093680
NPY2 RECEPTOR AGONISTS Nov 9, 2020 Abandoned
Array ( [id] => 18545314 [patent_doc_number] => 11718654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => IL-2R-bg binding compounds [patent_app_type] => utility [patent_app_number] => 17/089515 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 69 [patent_no_of_words] => 75601 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089515 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/089515
IL-2R-bg binding compounds Nov 3, 2020 Issued
Array ( [id] => 16807871 [patent_doc_number] => 20210130424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => DUAL IL-2R AND IL-7R BINDING COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/089533 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/089533
Dual IL-2R and IL-7R binding compounds Nov 3, 2020 Issued
Array ( [id] => 17119661 [patent_doc_number] => 11130783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => CD40 targeted peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 17/089463 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 75269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/089463
CD40 targeted peptides and uses thereof Nov 3, 2020 Issued
Array ( [id] => 16629594 [patent_doc_number] => 20210048247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS [patent_app_type] => utility [patent_app_number] => 17/081484 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/081484
METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS Oct 26, 2020 Abandoned
Array ( [id] => 18064470 [patent_doc_number] => 20220395557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH RECOMBINANT CFH PROTEINS [patent_app_type] => utility [patent_app_number] => 17/771334 [patent_app_country] => US [patent_app_date] => 2020-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771334 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/771334
METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH RECOMBINANT CFH PROTEINS Oct 22, 2020 Abandoned
Array ( [id] => 18027803 [patent_doc_number] => 11510964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth [patent_app_type] => utility [patent_app_number] => 17/072409 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 39 [patent_no_of_words] => 13707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/072409
Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth Oct 15, 2020 Issued
Array ( [id] => 16868535 [patent_doc_number] => 20210162002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS [patent_app_type] => utility [patent_app_number] => 17/072951 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072951 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/072951
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS Oct 15, 2020 Abandoned
Array ( [id] => 18254330 [patent_doc_number] => 20230081369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => IFIT Polypeptides and Uses for Treating Tuberculosis Infection [patent_app_type] => utility [patent_app_number] => 17/767734 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11350 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767734 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767734
IFIT Polypeptides and Uses for Treating Tuberculosis Infection Oct 7, 2020 Pending
Array ( [id] => 18241470 [patent_doc_number] => 20230073781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination [patent_app_type] => utility [patent_app_number] => 17/767099 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767099 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767099
Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination Oct 6, 2020 Pending
Array ( [id] => 17052179 [patent_doc_number] => 20210261613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => AROMATIC-CATIONIC PEPTIDES AND USES OF SAME [patent_app_type] => utility [patent_app_number] => 17/064937 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064937 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/064937
AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Oct 6, 2020 Abandoned
Array ( [id] => 18368141 [patent_doc_number] => 11648289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Antibacterial method [patent_app_type] => utility [patent_app_number] => 17/060648 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16855 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060648
Antibacterial method Sep 30, 2020 Issued
Array ( [id] => 16598057 [patent_doc_number] => 20210024588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => ANTIBACTERIAL METHOD [patent_app_type] => utility [patent_app_number] => 17/060592 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060592
ANTIBACTERIAL METHOD Sep 30, 2020 Abandoned
Array ( [id] => 19050867 [patent_doc_number] => 20240092836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/767550 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767550
Cyclic peptide having CTLA-4 inhibitory activity and use thereof Sep 29, 2020 Issued
Array ( [id] => 18004857 [patent_doc_number] => 20220363623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => IMAGING AND THERAPEUTIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/642505 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642505 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642505
IMAGING AND THERAPEUTIC COMPOSITIONS Sep 17, 2020 Pending
Array ( [id] => 16870090 [patent_doc_number] => 20210163557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY [patent_app_type] => utility [patent_app_number] => 17/018450 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018450 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/018450
METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY Sep 10, 2020 Abandoned
Array ( [id] => 17867059 [patent_doc_number] => 20220289794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => SYNTHETIC ANTIMICROBIAL PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/639082 [patent_app_country] => US [patent_app_date] => 2020-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/639082
SYNTHETIC ANTIMICROBIAL PEPTIDES Aug 30, 2020 Abandoned
Menu